CAS 544707-20-2

JNJ-10181457 (hydrochloride)

CAS : 544707-20-2

JNJ-10181457 (hydrochloride) is a non-imidazole H3 receptor antagonist that is brain-penetrating and selective, increasing NE and acetylcholine concentrations

Formule : C₂₀H₃₀Cl₂N₂O

Couleur et forme : Solid

Masse moléculaire : 385.37

Ref: TM-T37220

Jnj 10181457 dihydrochloride

CAS : 544707-20-2

JNJ 10181457 is a modulator of the modulation of acetylcholine and noradrenaline. It binds to an antigen in the brain, which is believed to be involved in Alzheimer's disease. JNJ 10181457 has been studied in clinical trials for the treatment of Alzheimer's disease. This drug also has potential for use as an immunotherapy for autoimmune diseases and cancer. JNJ 10181457 is a wake-promoting agent that interacts with dopamine receptors, but it also has antipsychotic effects due to its binding to H1 receptors. JNJ 10181457 also has anti-hyperactivity properties, which are likely related to its interactions with histamine receptors.

Formule : C₂₀H₃₀Cl₂N₂O

Degré de pureté : Min. 95%

Masse moléculaire : 385.4 g/mol

Ref: 3D-UWA70720